BioXcel Therapeutics, Inc.
เพิ่มขึ้น

BTAI BioXcel Therapeutics Options Ahead of Earnings

Analyzing the options chain and the chart patterns of BTAI BioXcel Therapeutics prior to the earnings report this week,
I would consider purchasing the 3usd strike price Calls with
an expiration date of 2024-3-15,
for a premium of approximately $0.25.
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.


bioxcelBTAIFundamental AnalysisTechnical IndicatorsoptionbuyingoptionsellingoptionsstrategyoptionstrategiesoptiontradingtradingcourseTrend Analysis

และใน:

คำจำกัดสิทธิ์ความรับผิดชอบ